Patent · US Active

Bispecific EGFR/c-Met antibodies

US9695242B2 · kind B2 · utility

5Cited by
20References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2016
Grant dateJul 4, 2017
Priority date—
Expiry dateDec 21, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2318/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Bispecific EGFR/c-Met antibodies and methods of making and using the molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.